Related Experiment Videos

C-reactive protein and disease activity in children with Crohn's disease

Samantha Tilakaratne1, Daniel A Lemberg, Steven T Leach

  • 1Department of Gastroenterology, Sydney Children's Hospital, High Street, Randwick, Sydney, NSW 2031, Australia.

Digestive Diseases and Sciences
|October 16, 2009
PubMed

Insights

C-reactive protein is a useful marker for assessing disease activity in children with Crohn's disease (CD). Measurements correlate well with disease severity and other inflammatory markers, aiding in patient management.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Biomarker Analysis

Background:

  • Monitoring disease activity in pediatric Crohn's disease (CD) relies on various markers.
  • The utility of C-reactive protein (CRP) as a disease activity indicator in children with CD requires further evaluation.
  • Comparison with existing markers is essential for validating new assessment tools.

Purpose of the Study:

  • To evaluate the usefulness of C-reactive protein (CRP) measurements in assessing disease activity in pediatric Crohn's disease (CD).
  • To compare the efficacy of CRP with other established markers for disease activity monitoring in children with CD.

Main Methods:

  • Retrospective analysis of outpatient visit data from 63 children with Crohn's disease (CD).
  • Inclusion of disease activity scores, C-reactive protein (CRP) levels, and other inflammatory markers.
  • Statistical correlation analysis between CRP values and disease activity indices.

Main Results:

  • C-reactive protein (CRP) values showed a significant positive correlation with disease activity (P < 0.0001).
  • Children with inactive CD had significantly lower CRP levels than those with mild disease (P < 0.001).
  • CRP levels demonstrated a strong correlation with Erythrocyte Sedimentation Rate (ESR) (P < 0.0001).

Conclusions:

  • C-reactive protein (CRP) measurement is a valuable tool for assessing disease activity in pediatric Crohn's disease (CD).
  • CRP levels correlate effectively with validated measures of disease activity and other inflammatory markers.
  • CRP offers a reliable method for monitoring disease status in children with CD.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...